Clariane in the lower part of the SBF 120, but still up 2.5% over one month
The operator of medicalised care homes and home healthcare services is taking a pause after the sharp rebound of the previous day. It is falling in a stable Parisian market and sits in the lower part of the broader index table.
A decline that brings the stock back to around €3.40, in the lower part of the SBF 120
The stock of Clariane loses 2.07% to €3.40, while the SBF 120 gains 0.05% at the close. This decline follows a session in which the stock was among the strongest gainers in the index, rising 1.75%. It places the stock among the biggest decliners in the SBF 120 for the session. It leaves the monthly gains intact (+2.47%), but the quarter remains down 15%.
The stock trades above its 20-day moving average at €3.30 (a gap of 3.03%), without having left it, and below its 50-day moving average at €3.53 as well as its 200-day moving average at €3.86. Emeis, another listed player in the sector, falls 1.04% at the close.
2026 targets confirmed at the publication of October 28
At the publication of its activity for the first nine months, on October 28, 2026, the group stated that it confirmed all of its operational and financial targets. Third-quarter revenue then stood at €1,352M, up 4.9% on an organic basis, driven by the rise in the occupancy rate of medicalised care homes.
Among the risks cited on this occasion is the dependence on the gradual improvement of occupancy rates. On the share price side, the support at €3.11 and the resistance at €3.51 now frame the stock's movement, whose RSI at 50 remains neutral.
